G₁/S cell cycle proteins as markers of aggressive prostate carcinomaKIBEL, A. S; ISAACS, W. B.Urology (Ridgewood, NJ). 2000, Vol 55, Num 3, pp 316-322, issn 0090-4295Article

Cotranslational assembly of myosin heavy chain in developing cultured skeletal muscleISAACS, W. B; FULTON, A. B.Proceedings of the National Academy of Sciences of the United States of America. 1987, Vol 84, Num 17, pp 6174-6178, issn 0027-8424Article

Immunological localization and quantitation of the androgen-dependent secretory protease of the canine prostateISAACS, W. B; SHAPER, J. H.Endocrinology (Philadelphia). 1985, Vol 117, Num 4, pp 1512-1520, issn 0013-7227Article

Prostate cancer risk in men with prostate and breast cancer family history: results from the REDUCE study (R1)THOMAS, J.-A; GERBER, L; MOREIRA, D. M et al.Journal of internal medicine. 2012, Vol 272, Num 1, pp 85-92, issn 0954-6820, 8 p.Article

Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cellsJARRARD, D. F; KINOSHITA, H; YAN SHI et al.Cancer research (Baltimore). 1998, Vol 58, Num 23, pp 5310-5314, issn 0008-5472Article

Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide searchSMITH, J. R; FREIJE, D; NUSSKERN, D. R et al.Science (Washington, D.C.). 1996, Vol 274, Num 5291, pp 1371-1374, issn 0036-8075Article

Regional loss of imprinting of the insulin-like growth factor II gene occurs in human prostate tissuesJARRARD, D. F; BUSSEMAKERS, M. J. G; BOVA, G. S et al.Clinical cancer research. 1995, Vol 1, Num 12, pp 1471-1478, issn 1078-0432Article

Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancerUMBAS, R; ISAACS, W. B; BRINGUIER, P. P et al.Cancer research (Baltimore). 1994, Vol 54, Num 14, pp 3929-3933, issn 0008-5472Article

Mutations of the VHL tumour suppressor gene in renal carcinomaGNARRA, J. R; TORY, K; LUBENSKY, I et al.Nature genetics. 1994, Vol 7, Num 1, pp 85-90, issn 1061-4036Article

Hereditary prostate cancer : epidemiologic and clinical featuresCARTER, B. S; BOVA, G. S; BEATY, T. H et al.The Journal of urology. 1993, Vol 150, Num 3, pp 797-802, issn 0022-5347Article

Tumor suppressor gene allelic loss in human renal cancersBROOKS, J. D; BOVA, G. S; MARSHALL, F. F et al.The Journal of urology. 1993, Vol 150, Num 4, pp 1278-1283, issn 0022-5347Article

Effect of pentosan, a novel cancer chemotherapeutic agent, on prostate cancer cell growth and motilityPIENTA, K. J; MURPHY, B. C; ISAACS, W. B et al.The Prostate. 1992, Vol 20, Num 3, pp 233-241, issn 0270-4137Article

Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastasesHUA ZHONG; DE MARZO, A. M; LAUGHNER, E et al.Cancer research (Baltimore). 1999, Vol 59, Num 22, pp 5830-5835, issn 0008-5472Article

Biological aggressiveness of hereditary prostate cancer : Long-term evaluation following radical prostatectomyBOVA, G. S; PARTIN, A. W; ISAACS, S. D et al.The Journal of urology. 1998, Vol 160, Num 3, pp 660-663, issn 0022-5347, 1Article

Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissuesSUZUKI, H; FREIJE, D; NUSSKERN, D. R et al.Cancer research (Baltimore). 1998, Vol 58, Num 2, pp 204-209, issn 0008-5472Article

Molecular genetics of prostate cancer : Clinical applicationsMORTON, R. A; ISAACS, W. B.Journal of the National Medical Association. 1998, Vol 90, Num 11, pp S728-S731, issn 0027-9684, SUPConference Paper

Characteristics of prostate cancer in families potentially linked to the hereditary prostate Cancer 1 (HPC1) locusGRÖNBERG, H; ISAACS, S. D; WALSH, P. C et al.JAMA, the journal of the American Medical Association. 1997, Vol 278, Num 15, pp 1251-1255, issn 0098-7484Article

Relation between aberrant α-catenin expression and loss of E-cadherin function in prostate cancerUMBAS, R; ISAACS, W. B; BRINGUIER, P. P et al.International journal of cancer. 1997, Vol 74, Num 4, pp 374-377, issn 0020-7136Article

Early age at diagnosis in families providing evidence of linkage to the hereditary prostate cancer locus (HPC1) on chromosome 1GRÖNBERG, H; XU, J; MEYERS, D. A et al.Cancer research (Baltimore). 1997, Vol 57, Num 21, pp 4707-4709, issn 0008-5472Article

Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic lossDONG, J.-T; SUZUKI, H; PIN, S. S et al.Cancer research (Baltimore). 1996, Vol 56, Num 19, pp 4387-4390, issn 0008-5472Article

Review of allelic loss and gain in prostate cancerBOVA, G. S; ISAACS, W. B.World journal of urology (Print). 1996, Vol 14, Num 5, pp 338-346, issn 0724-4983Article

Microsatellite mutation (CAG_14-28) in the androgen receptor gene in human prostate cancerSCHOENBERG, M. P; HAKIMI, J. M; SUPING WANG et al.Biochemical and biophysical research communications (Print). 1994, Vol 198, Num 1, pp 74-80, issn 0006-291XArticle

Reduction of E-cadherin levels and deletion of the α-catenin gene in human prostate cancer cellsMORTON, R. A; EWING, C. M; NAGAFUCHI, A et al.Cancer research (Baltimore). 1993, Vol 53, Num 15, pp 3585-3590, issn 0008-5472Article

New approaches to the evaluation of the metastatic ability of renal cancer and new approaches to chemotherapyISAACS, W. B; ISAACS, J. T; KYPRIANOU, N et al.European urology. 1990, Vol 18, pp 33-35, issn 0302-2838, 3 p., suppl. 2Article

Cadherin-6, a cell adhesion molecule specifically expressed in the proximal renal tubule and renal cell carcinomaPAUL, R; EWING, C. M; ROBINSON, J. C et al.Cancer research (Baltimore). 1997, Vol 57, Num 13, pp 2741-2748, issn 0008-5472Article